"92400" . . "In the last two years there has been a fundamental change in the treatment of chronic hepatitis C virus (HCV) infection. The base of this change is the commercial availability of protease inhibitors \u2013 telaprevir and boceprevir, administered in combination with pegylated interferon alpha and ribavirin for genotype 1 infection HCV therapy. In the following years, you can expect the gradual placing on the market of other drugs effective against HCV, and that different genotypes, which will be administered either in combination with pegylated interferon alpha and Ribavirin, or it will be a combination of only orally administered drugs: interferon (IFN)-free regimes."@en . "1805-398X" . "1"^^ . "News in the treatment of chronic hepatitis C"@en . . . "CZ - \u010Cesk\u00E1 republika" . . "chronic hepatitis C virus; HCV; telaprevir; boceprevir"@en . "1"^^ . "2013" . . . "V posledn\u00EDch dvou letech do\u0161lo k z\u00E1sadn\u00ED zm\u011Bn\u011B v mo\u017Enostech l\u00E9\u010Dby chronick\u00E9 infekce virem hepatitidy C (HCV). Podstatou t\u00E9to zm\u011Bny je komer\u010Dn\u00ED dostupnost prote\u00E1zov\u00FDch inhibitor\u016F - telapreviru a bocepreviru, pod\u00E1van\u00FDch v kombinaci s pegylovan\u00FDm interferonem alfa a ribavirinem - pro terapii infekce genotypem 1 HCV. V n\u00E1sleduj\u00EDc\u00EDch letech lze o\u010Dek\u00E1vat postupn\u00E9 uv\u00E1d\u011Bn\u00ED na trh dal\u0161\u00EDch l\u00E9k\u016F \u00FA\u010Dinn\u00FDch proti HCV, a to r\u016Fzn\u00FDch genotyp\u016F, kter\u00E9 se budou pod\u00E1vat bu\u010F v kombinaci s pegylovan\u00FDm interferonem alfa a ribavirinem, nebo p\u016Fjde o kombinaci pouze or\u00E1ln\u011B pod\u00E1van\u00FDch l\u00E9k\u016F v tzv. interferon (IFN)-free re\u017Eimech." . . . "7" . "V posledn\u00EDch dvou letech do\u0161lo k z\u00E1sadn\u00ED zm\u011Bn\u011B v mo\u017Enostech l\u00E9\u010Dby chronick\u00E9 infekce virem hepatitidy C (HCV). Podstatou t\u00E9to zm\u011Bny je komer\u010Dn\u00ED dostupnost prote\u00E1zov\u00FDch inhibitor\u016F - telapreviru a bocepreviru, pod\u00E1van\u00FDch v kombinaci s pegylovan\u00FDm interferonem alfa a ribavirinem - pro terapii infekce genotypem 1 HCV. V n\u00E1sleduj\u00EDc\u00EDch letech lze o\u010Dek\u00E1vat postupn\u00E9 uv\u00E1d\u011Bn\u00ED na trh dal\u0161\u00EDch l\u00E9k\u016F \u00FA\u010Dinn\u00FDch proti HCV, a to r\u016Fzn\u00FDch genotyp\u016F, kter\u00E9 se budou pod\u00E1vat bu\u010F v kombinaci s pegylovan\u00FDm interferonem alfa a ribavirinem, nebo p\u016Fjde o kombinaci pouze or\u00E1ln\u011B pod\u00E1van\u00FDch l\u00E9k\u016F v tzv. interferon (IFN)-free re\u017Eimech."@cs . . "Novinky v l\u00E9\u010Db\u011B chronick\u00E9 hepatitidy C" . . "Acta medicinae" . "RIV/00216224:14110/13:00069617" . . . "Husa, Petr" . "Novinky v l\u00E9\u010Db\u011B chronick\u00E9 hepatitidy C"@cs . "Novinky v l\u00E9\u010Db\u011B chronick\u00E9 hepatitidy C" . "I" . . "News in the treatment of chronic hepatitis C"@en . . . . "14110" . "Novinky v l\u00E9\u010Db\u011B chronick\u00E9 hepatitidy C"@cs . "3"^^ . "[6C302F0B7221]" . "RIV/00216224:14110/13:00069617!RIV14-MSM-14110___" .